Literature DB >> 25929954

Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.

Luke W Garratt1, Erika N Sutanto2, Kak-Ming Ling3, Kevin Looi4, Thomas Iosifidis5, Kelly M Martinovich3, Nicole C Shaw3, Elizabeth Kicic-Starcevich2, Darryl A Knight6, Sarath Ranganathan7, Stephen M Stick8, Anthony Kicic9.   

Abstract

Neutrophil elastase is the most significant predictor of bronchiectasis in early-life cystic fibrosis; however, the causal link between neutrophil elastase and airway damage is not well understood. Matrix metalloproteinases (MMPs) play a crucial role in extracellular matrix modelling and are activated by neutrophil elastase. The aim of this study was to assess if MMP activation positively correlates with neutrophil elastase activity, disease severity and bronchiectasis in young children with cystic fibrosis.Total MMP-1, MMP-2, MMP-7, MMP-9, tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-1 levels were measured in bronchoalveolar lavage fluid collected from young children with cystic fibrosis during annual clinical assessment. Active/pro-enzyme ratio of MMP-9 was determined by gelatin zymography. Annual chest computed tomography imaging was scored for bronchiectasis.A higher MMP-9/TIMP-1 ratio was associated with free neutrophil elastase activity. In contrast, MMP-2/TIMP-2 ratio decreased and MMP-1 and MMP-7 were not detected in the majority of samples. Ratio of active/pro-enzyme MMP-9 was also higher in the presence of free neutrophil elastase activity, but not infection. Across the study cohort, both MMP-9/TIMP-1 and active MMP-9 were associated with progression of bronchiectasis.Both MMP-9/TIMP-1 and active MMP-9 increased with free neutrophil elastase and were associated with bronchiectasis, further demonstrating that free neutrophil elastase activity should be considered an important precursor to cystic fibrosis structural disease.
Copyright ©ERS 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25929954     DOI: 10.1183/09031936.00212114

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

Review 1.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

2.  CrossTalk opposing view: mucosal acidification does not drive early progressive lung disease in cystic fibrosis.

Authors:  Stephen M Stick; André Schultz
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

3.  Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Authors:  Benjamin T Kopp; James Fitch; Lisa Jaramillo; Chandra L Shrestha; Frank Robledo-Avila; Shuzhong Zhang; Sabrina Palacios; Fred Woodley; Don Hayes; Santiago Partida-Sanchez; Octavio Ramilo; Peter White; Asuncion Mejias
Journal:  J Cyst Fibros       Date:  2019-08-29       Impact factor: 5.482

4.  Pseudomonas aeruginosa in the Cystic Fibrosis Lung.

Authors:  John King; Ronan Murphy; Jane C Davies
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic Fibrosis.

Authors:  Camilla Margaroli; Luke W Garratt; Hamed Horati; A Susanne Dittrich; Timothy Rosenow; Samuel T Montgomery; Dario L Frey; Milton R Brown; Carsten Schultz; Lokesh Guglani; Anthony Kicic; Limin Peng; Bob J Scholte; Marcus A Mall; Hettie M Janssens; Stephen M Stick; Rabindra Tirouvanziam
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

Review 6.  Targeting Proteases in Cystic Fibrosis Lung Disease. Paradigms, Progress, and Potential.

Authors:  Michael C McKelvey; Sinéad Weldon; Daniel F McAuley; Marcus A Mall; Clifford C Taggart
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

7.  Elastase inhibitor agaphelin protects from acute ischemic stroke in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.

Authors:  Jonas Leinweber; Daniella M Mizurini; Ivo M B Francischetti; Michael Fleischer; Dirk M Hermann; Christoph Kleinschnitz; Friederike Langhauser
Journal:  Brain Behav Immun       Date:  2021-01-02       Impact factor: 7.217

8.  Lung inflammation and simulated airway resistance in infants with cystic fibrosis.

Authors:  Emily M DeBoer; Julia S Kimbell; Kaci Pickett; Joseph E Hatch; Kathryn Akers; John Brinton; Graham L Hall; Louise King; Fiona Ramanauskas; Tim Rosenow; Stephen M Stick; Harm A Tiddens; Thomas W Ferkol; Sarath C Ranganathan; Stephanie D Davis
Journal:  Respir Physiol Neurobiol       Date:  2021-06-19       Impact factor: 1.931

Review 9.  Neutrophil signaling during myocardial infarction wound repair.

Authors:  Michael J Daseke; Upendra Chalise; Mediha Becirovic-Agic; Jeffrey D Salomon; Leah M Cook; Adam J Case; Merry L Lindsey
Journal:  Cell Signal       Date:  2020-10-24       Impact factor: 4.315

Review 10.  Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease.

Authors:  Michael C McKelvey; Ryan Brown; Sinéad Ryan; Marcus A Mall; Sinéad Weldon; Clifford C Taggart
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.